Gen2 Isthmus-Dependent Atrial Flutter Ablation Study

N/ATerminatedNCT00606463

Abbott Medical Devices30 enrolled

Overview

Irrigated catheter for ablation of isthmus-dependent atrial flutter

This study intends to use an investigational irrigated catheter for ablation of isthmus-dependent atrial flutter

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Atrial Flutter

Interventions

Cardiac Ablation (Gen2 Cardiac Ablation System)DEVICE

Ablation of isthmus-dependent atrial flutter

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Scheduled for ablation of isthmus-dependent atrial flutter Exclusion Criteria: * Prior ablation of isthmus-dependent atrial flutter * Atypical or scar flutter * Significant heart disease * Intracardiac thrombus * Prior cardiac surgery (within 1 month) * Contraindication to heparin

Locations (3)

University of Alabama Birmingham

Birmingham, Alabama, United States

St. Barnabus Medical Center

West Orange, New Jersey, United States

Doylestown Hospital

Doylestown, Pennsylvania, United States

Outcomes

Primary Outcomes

Incidence of intraprocedural, serious cardiac adverse event

Defined as the Incidence of intraprocedural, serious cardiac adverse event

Time frame: 7 days post-procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.